Literature DB >> 15219678

Cytoplasmic p21(Cip1/WAF1) enhances axonal regeneration and functional recovery after spinal cord injury in rats.

H Tanaka1, T Yamashita, K Yachi, T Fujiwara, H Yoshikawa, M Tohyama.   

Abstract

p21(Cip1/WAF1), known as a cell-cycle inhibitory protein, facilitates neurite outgrowth from neurons when present in the cytoplasm. The molecular mechanism of this action is that p21(Cip1/WAF1) forms a complex with Rho-kinase and inhibits its activity. As myelin-derived inhibitors of axonal outgrowth act on neurons by activating Rho, that is responsible for the lack of spontaneous regeneration of the injured central nervous system (CNS), Rho-kinase may be a good molecular target against injuries in the CNS. In this study, we delivered TAT-fusion protein of cytoplasmic p21(Cip1/WAF1) locally after dorsal hemisection of the thoracic spinal cord in rats. The treatment significantly stimulated axonal regeneration and recovery of hindlimb function, and inhibited the cavity formation in the spinal cord after the injury. Cytoplasmic p21(Cip1/WAF1) may provide a potential therapeutic agent that produces functional regeneration following CNS injuries.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219678     DOI: 10.1016/j.neuroscience.2004.05.010

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  48 in total

1.  Effect of subcellular localization of P21 on proliferation and apoptosis of HepG2 cells.

Authors:  Rongyuan Qiu; Songbai Wang; Xihua Feng; Feng Chen; Kaikai Yang; Shengsong He
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

2.  Krüppel-like Factor 7 engineered for transcriptional activation promotes axon regeneration in the adult corticospinal tract.

Authors:  Murray G Blackmore; Zimei Wang; Jessica K Lerch; Dario Motti; Yi Ping Zhang; Christopher B Shields; Jae K Lee; Jeffrey L Goldberg; Vance P Lemmon; John L Bixby
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-23       Impact factor: 11.205

Review 3.  Spinal cord injury: a systematic review of current treatment options.

Authors:  David W Cadotte; Michael G Fehlings
Journal:  Clin Orthop Relat Res       Date:  2011-03       Impact factor: 4.176

4.  CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.

Authors:  Natalia G Starostina; Jennifer M Simpliciano; Michael A McGuirk; Edward T Kipreos
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

5.  HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanism.

Authors:  Kelly A Krogh; Elizabeth Lyddon; Stanley A Thayer
Journal:  J Neurochem       Date:  2014-09-18       Impact factor: 5.372

6.  ROCK inhibition produces anxiety-related behaviors in mice.

Authors:  Akiyoshi Saitoh; Mitsuhiko Yamada; Misa Yamada; Shinya Kobayashi; Noritaka Hirose; Kazuo Honda; Junzo Kamei
Journal:  Psychopharmacology (Berl)       Date:  2006-07-13       Impact factor: 4.530

Review 7.  The role of repulsive guidance molecules in the embryonic and adult vertebrate central nervous system.

Authors:  Bernhard K Mueller; Toshihide Yamashita; Gregor Schaffar; Reinhold Mueller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-09-29       Impact factor: 6.237

8.  Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositis.

Authors:  Bumsup Kwon; Pravir Kumar; Han-Kyu Lee; Ling Zeng; Kenneth Walsh; Qinghao Fu; Amey Barakat; Henry W Querfurth
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

9.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

Review 10.  A systematic review of directly applied biologic therapies for acute spinal cord injury.

Authors:  Brian K Kwon; Elena B Okon; Ward Plunet; Darryl Baptiste; Karim Fouad; Jessica Hillyer; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-06-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.